This notwithstanding, as cancer progresses to the more malignant stages, patients inevitably develop cancer-induced hypercalcemia (49–52) which may invariably influence the progression of the disease via the CaSR or independent of CaSR. This evidence concerns the gene CASR and hypercalcemia disease.